Accordingly, studies on IR and CRC risk used the homeostasis model of insulin resistance (HOMA-IR), circulating C-peptide, or insulin-like growth factor 1 (IGF1-) as measures of IR and insulin production [7–12]. This evidence concerns the gene INS and colorectal carcinoma.